Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10111939 Albumin-free botulinum toxin formulations

Patent 10111939 was granted and assigned to Revance Therapeutics, Inc. on October, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 2 Mar, 2024

"update inverses"

Golden AI

edited on 2 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11911449 Albumin-free botulinum toxin formulations

Edits on 8 Dec, 2023

"Add patent abstract"

Golden AI

edited on 8 Dec, 2023

Edits made to:

Article (+234 characters)

Article

Patent abstract

This invention relates to botulinum toxin formulations that are stabilized without the use of any proteinaceous excipients. The invention also relates to methods of preparing and using such botulinum toxin formulations.

Edits on 1 Oct, 2023

"Add patent inventor(s)"

Golden AI

edited on 1 Oct, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

Curtis L. Ruegg0

Jacob M. Waugh0

Stewart A. Thompson0

Edits on 25 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 25 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 10973890 Non-protein clostridial toxin compositions

Edits on 24 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 24 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11351232 Albumin-free botulinum toxin formulations

Edits on 6 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 6 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11524075 Animal protein-free pharmaceutical compositions

Edits on 1 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 1 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11285216 Animal protein-free pharmaceutical compositions

Edits on 24 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 24 Mar, 2023

Infobox

Patent Citations Received

‌

US Patent 11311496 Transdermal delivery of large agents

Edits on 8 Mar, 2023

"update inverses"

Golden AI

edited on 8 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11596673 Long lasting effect of new botulinum toxin formulations

Edits on 14 Dec, 2022

"update inverses"

Golden AI

edited on 14 Dec, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11524075 Animal protein-free pharmaceutical compositions

Edits on 12 Oct, 2022

"update inverses"

Golden AI

edited on 12 Oct, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11466262 Methods and systems for purifying non-complexed

Edits on 28 Sep, 2022

"Entity importer update"

Golden AI

edited on 28 Sep, 2022

Infobox

Is a

Patent

Patent Applicant

‌

Revance Therapeutics, Inc.

Current Assignee

‌

Revance Therapeutics, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

101119390

Date of Patent

October 30, 2018

Patent Application Number

151553410

Date Filed

May 16, 2016

Patent Citations Received

‌

US Patent 10744078 Compositions and methods for topical application and transdermal delivery of botulinum toxins

‌

US Patent 10973890 Non-protein clostridial toxin compositions

‌

US Patent 11285216 Animal protein-free pharmaceutical compositions

‌

US Patent 11311496 Transdermal delivery of large agents

‌

US Patent 11351232 Albumin-free botulinum toxin formulations

‌

US Patent 11446382 Animal protein-free pharmaceutical compositions

Patent Primary Examiner

‌

Nita M. Minnifield

Edits on 27 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 27 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 11311496 Transdermal delivery of large agents

"update citations for inverse infoboxes"

Golden AI

edited on 26 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 11351232 Albumin-free botulinum toxin formulations

Edits on 25 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 25 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 10973890 Non-protein clostridial toxin compositions

Edits on 21 Sep, 2022

"update inverses"

Golden AI

edited on 21 Sep, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11446382 Animal protein-free pharmaceutical compositions

Edits on 9 Jun, 2022

"update inverses"

Golden AI

edited on 9 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 11351232 Albumin-free botulinum toxin formulations

Edits on 19 May, 2022

"update inverses"

Golden AI

edited on 19 May, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 11311496 Transdermal delivery of large agents

Edits on 30 Mar, 2022

"update inverses"

Golden AI

edited on 30 Mar, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 11285216 Animal protein-free pharmaceutical compositions

Edits on 11 Feb, 2022

"update inverses"

Golden AI

edited on 11 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 10973890 Non-protein clostridial toxin compositions

Find more entities like US Patent 10111939 Albumin-free botulinum toxin formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.